ELITE PHARMACEUTICALS INC Intellectual Property Contracts & Agreements
20 Contracts & Agreements
- License Agreements (20 contracts)
- License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals and Lannett, Inc., dated July 20, 2021 (Filed With SEC on June 29, 2022)
- License and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Dexcel Ltd. (Or Akiva, Israel), dated December 6, 2021 (Filed With SEC on June 29, 2022)
- License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Lannett Company, Inc, dated October 18, 2021 (Filed With SEC on June 29, 2022)
- License, Supply, and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Lannett Company, Inc, dated October 18, 2021 (Filed With SEC on June 29, 2022)
- Master Development and License Agreement for Products Between Elite Pharmaceuticals, Inc. and Mikah Pharma LLC, effective as of June 10, 2021.(Portions of this Agreement have been... (Filed With SEC on August 16, 2021)
- July 29, 2019 Amendment To The License, Supply And Distribution Agreement Between Elite Pharmaceuticals, Inc./Elite Laboratories, Inc. And Lannett Company, Inc. (Portions of this... (Filed With SEC on June 14, 2021)
- July 29, 2019 Amendment To The License, Supply And Distribution Agreement Between Elite Pharmaceuticals, Inc./Elite Laboratories, Inc. And Lannett Company, Inc. (Portions of this... (Filed With SEC on June 29, 2020)
- January 2, 2020 Amendment to the Glenmark Pharmaceuticals Inc. USA License, Supply and Distribution Agreement (portions of this Agreement have been redacted in compliance with... (Filed With SEC on February 10, 2020)
- License, Supply And Distribution Agreement effective March 6, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA... (Filed With SEC on February 10, 2020)
- August 1, 2018 Amendment to the Glenmark Pharmaceuticals Inc. USA License, Supply and Distribution Agreement (portions of this Agreement have been redacted in compliance with... (Filed With SEC on February 10, 2020)
- License, Supply And Distribution Agreement effective March 6, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA... (Filed With SEC on June 21, 2019)
- License, Supply And Distribution Agreement effective April 9, 2019 by and between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA... (Filed With SEC on June 21, 2019)
- FIRST AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN PHARMA, LLC (Filed With SEC on August 9, 2017)
- SECOND AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN PHARMA, LLC (Filed With SEC on August 9, 2017)
- MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN (Filed With SEC on August 9, 2017)
- MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN (Filed With SEC on November 9, 2016)
- LICENSE AGREEMENT (Filed With SEC on June 15, 2015)
- MANUFACTURING AND LICENSE AGREEMENT Between Elite Pharmaceuticals, Inc. and Epic Pharma LLC (Filed With SEC on November 14, 2013)
- Exhibit 10. 77 MASTER DEVELOPMENT AND LICENSE AGREEMENTFOR PRODUCT BETWEEN ELITE PHARMACEUTICALS, INC. AND {***} (Filed With SEC on June 29, 2012)
- AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR {***} BETWEEN ELITE PHARMACEUTICALS, INC. AND MIKAH PHARMA, LLC (Filed With SEC on November 14, 2011)
